Five departments work together to check the quality hidden dangers of online drug companies, and they will interview the person in charge

On March 14, 2013, Beijing food and Drug Administration destroyed more than 50 tons of fake drugs Yesterday, the State Food and Drug Administration held a press conference The meeting reported that the State Food and drug administration, together with many departments, will focus on six months to carry out a nationwide "two dozen and two constructions" special action with the main contents of "severely crack down on illegal drug production, severely crack down on illegal drug operation, strengthen the construction of standardized drug production and operation and drug regulatory mechanism" The key points of "fighting" include illegal production of traditional Chinese medicine, adulteration of traditional Chinese medicine market, illegal drug sale on the Internet, etc.; the key points of "building" include establishing enterprise risk management and drug safety risk warning interview system, etc In the first ten days of August, the State Food and drug administration, together with the state Internet Information Office, the Ministry of industry and information technology, the Ministry of public security and the State Administration for Industry and commerce, will launch a campaign against illegal drug sales on the Internet, We will carry out the rectification of online drug sales, and solve the problems of using the Internet to publish false information and sell fake and substandard drugs Li Guoqing, head of the drug and cosmetic Supervision Department of the State Food and drug administration, said that the problem of illegal online drug sales, including the sale of fake drugs, is very prominent and has become a social hazard At present, there are mainly problems such as illegal release of drug information on the Internet, exaggeration of publicity, exaggeration of efficacy, etc.; some legal websites sell drugs in violation of regulations and sell drugs that should not be sold; the third most prominent problem is selling fake drugs The network has become the main channel of counterfeit medicine sales In addition to investigating and punishing according to their respective functions, the participating departments of this action will also jointly supervise and form a normal cooperation mechanism We will focus on cracking down on the sale of fake and substandard drugs on the Internet or the sale of non drugs as fake drugs For websites that have obtained the qualification of Internet drug information service or drug transaction, and have published false drug information and illegal drug sales, they will be ordered to suspend business for rectification and rectification within a time limit until the qualification of Internet drug transaction is suspended For those websites that have not obtained the qualification and are engaged in drug sales illegally, the following measures will be taken: The law shall be transferred to the relevant departments for handling; those who sell fake drugs shall be transferred to the public security organ for criminal responsibility The relevant departments will also formulate regulations on the administration of drug sales on the Internet, strictly enforce qualification conditions and quality management requirements, and standardize drug sales on the Internet Yan Jiangying, a spokesman for the State Food and drug administration, said that at present, the food and drug administration has approved 95 individual drug websites When the public purchases drugs on the Internet, they should choose these websites with the qualification certificate of Internet drug trading service, and any problem can be complained Key 2 The eight departments of illegal production and marketing of traditional Chinese medicine jointly renovate the market of traditional Chinese medicine Recently, problems in traditional Chinese medicine have been exposed frequently To this end, in late August, the State Food and Drug Administration will work with seven departments to carry out joint rectification actions to strengthen the market management of traditional Chinese medicine Li Guoqing confessed that in the daily supervision work, the most common problem is that there are more problems in traditional Chinese medicine All links of the whole industrial chain, from problems caused by backward production methods in the process of planting and primary processing, problems in violation of regulations in the management of traditional Chinese medicine extracts, to problems such as the use of inferior drugs and illegal extracts in the process of traditional Chinese medicine, all kinds of problems have spread through the market of traditional Chinese medicine In late August, the State Food and Drug Administration will work with the Ministry of industry and information technology, the Ministry of agriculture, the Ministry of Commerce, the health and Family Planning Commission, the State Administration of industry and commerce, the forestry bureau and the Chinese medicine bureau to carry out market regulation of traditional Chinese medicine, implement the responsibilities of local governments and strengthen the market management of traditional Chinese medicine in accordance with the principle of "territorial management, who runs the business is responsible" If there are serious problems in the specialized market of traditional Chinese medicine and the rectification is not effective, it shall be resolutely closed down The general administration requires local governments to take effective measures to strengthen the management of traditional Chinese medicine planting, promote regionalization, standardization and scale; strengthen the management of primary processing of traditional Chinese medicine origin, standardize processing behavior, improve processing technology, and gradually improve the level of primary processing; strengthen the management of professional market transactions, strictly control the scope of transactions, and standardize trading behavior Encourage traditional Chinese medicine manufacturers to establish planting and production bases in the main production areas of traditional Chinese medicine to ensure the quality of traditional Chinese medicine is stable Yan said that the current problems only rely on the supervision of regulatory authorities, local governments, enterprises and the society, including the media, so as to make the development of the Chinese medicine market more standardized and make the treasures of traditional Chinese medicine more brilliant Carry out "open interview and accept public supervision" in self construction, first analyze the factors affecting drug safety, then set a number of indicators accordingly, and form a system Then evaluate according to the indicators and make a judgment on the risk level of the enterprise " Li Guoqing said that in this way, the potential safety hazards can be found earlier, and prevention is the main goal In terms of management, enterprises can be managed differently according to different risk levels to improve work efficiency and pertinence The risk level also represents the credit level and ability of enterprises The choice of consumers can make the enterprises with high risk level be eliminated naturally in the market competition   In the next step, the "three interviews" system will also be implemented: if the regulatory department finds that the quality management system of the enterprises within its jurisdiction has defects and may have hidden dangers, it shall promptly interview the person in charge of the enterprises; if it finds that the lower level regulatory department does not pay enough attention to the risk signals or takes inadequate measures, it shall timely interview the person in charge of the lower level regulatory department; if there are regional risks and the problems are complex, it shall We need to meet with the heads of local governments in a timely manner In addition, open interviews will also be carried out to actively accept social supervision and public opinion supervision Reporter: how to improve the deterrence of "fighting"? Mao Zhenbin, head of the Inspection Bureau of the State Food and drug administration, always stresses strict inspection, supervision and handling For the illegal acts found in the special actions, they must be severely investigated and dealt with according to the upper limit of the punishment of laws and regulations in accordance with the serious circumstances; for the drug production enterprises or business enterprises with serious illegal circumstances, their drug production or business licenses must be revoked; for the cases involving suspected criminal crimes, they must be transferred to the public security organs; for the fake drug products seized in the investigation and handling of cases, they must be severely investigated and dealt with It is necessary to take administrative coercive measures such as administrative seizure; for those who refuse to recall drugs with potential safety hazards or cause serious consequences, no matter the drug manufacturer or the drug distributor, their production and operation licenses will be revoked in accordance with the law If there is a report, it must be investigated; if there is a fake, it must be beaten We have now established administrative means of case clue sharing, joint supervision, joint investigation and joint exposure with the public security department, with zero tolerance for fake and substandard drugs Reporter: how to improve the blacklist system? Mao Zhenbin: all enterprises and individuals who seriously violate laws and regulations shall be listed in the "blacklist" and made public to the society For the enterprises listed in the "blacklist", they shall stop accepting the application of drug administrative license, and increase the frequency and intensity of supervision and inspection For the individuals listed in the "blacklist", it is prohibited to enter the industry according to law, and the relevant personnel shall not engage in the production and operation of relevant products within the prescribed time limit; if the circumstances are serious, they shall not engage in the production and operation of drugs for life.